CD14 and rheumatoid arthritis: The observation that GM-CSF receptor was demonstrated to be increased in CD14+ cells in RA (p < 0.05), and to a lesser extent, in PsA patients (Supplementary Figures 2A,B), suggested that the priming of RA monocytes was not due to an increase in the cytokine receptor.